.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,244,914

« Back to Dashboard

Details for Patent: 5,244,914

Title: Stable porfimer sodium compositions and methods for their manufacture
Abstract:A storage stable porfimer sodium (polyhematoporphyrin ether/ester) composition useful in the photodynamic therapy of cancer and other conditions is provided. The composition is characterized in that the percentage of ester linked porphyrin oligomers is less than 10% of the composition. Improved processes for preparing such compositions are also provided wherein acetylated hematoporphyrin is treated with alkali for sufficient time and temperature to reduce the amount of porphyrin oligomers joined by ester linkages to less than 10% of the composition.
Inventor(s): Clauss; Steven L. (Manville, NJ), Pastel; Michael J. (Highland Mills, NY), Zawadzki; Rainer K. (Wuhan, CN)
Assignee: American Cyanamid Company (Stamford, CT)
Filing Date:Apr 27, 1992
Application Number:07/873,860
Claims:1. A process for the preparation of a porfimer sodium pharmaceutical composition comprised of porphyrin oligomers having ether and ester linkages, which process comprises treating acetylated hematoporphyrin with alkali under conditions of alkali concentration, time and temperature which do not result in degradation but reduce the the percentage of ester linkages to less than 10% of the linkages in the composition.

2. A process according to claim 1 wherein the alkali is in a concentration range of 0.1N-1N.

3. The process of claim 1 wherein the alkali is sodium hydroxide, the concentration of alkali is 0.1N-1N, and the time and temperature conditions are one hour at room temperature, followed by 4.degree. C. for 14-21 days.

4. The process of claim 1 wherein the alkali is sodium hydroxide, the concentration of alkali is 0.1N-1N, and the time and temperature conditions are 16-24 hours at a temperature less than 45.degree. C.

5. The process of claim 1 wherein the alkali is sodium hydroxide, and the conditions are alkali concentration of 0.1N for one hour at room temperature followed by an alkali concentration of 0.2N-1N for 2-4 hours at room temperature.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc